Jian‐She Wang

2.3k citations
104 papers · 1.3k indexed · h-index 20
Topics
Pediatric Hepatobiliary Diseases and Treatments (46 papers)Drug Transport and Resistance Mechanisms (27 papers)Metabolism and Genetic Disorders (23 papers)

In The Last Decade

Jian‐She Wang

98 papers receiving 1.3k citations

Peers

Jian‐She Wang
Comparison fields: 5 of 98
  • Surgery 495
  • Epidemiology 459
  • Hepatology 360
  • Oncology 326
  • Molecular Biology 235
Replace K Tanikawa with:
K Tanikawa Japan
Martin Leníček Czechia
André Geubel Belgium
James L. Wisecarver United States
Hiroo Ohnishi Japan
Francesco Azzaroli Italy
Ian G. Renner United States
Yasuaki Nakajima Japan
Hikmet Akkız Türkiye
Toshio Mitomi Japan
Jian‐She Wang relative to K Tanikawa Japan K Tanikawa's profile →
Citations per field
00.5×6.1×
K Tanikawa · 1×
Citations per year

Countries citing papers authored by Jian‐She Wang

Since Specialization
Citations

This map shows the geographic impact of Jian‐She Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian‐She Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian‐She Wang more than expected).

Fields of papers citing papers by Jian‐She Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian‐She Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian‐She Wang. The network helps show where Jian‐She Wang may publish in the future.

Co-authorship network of co-authors of Jian‐She Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jian‐She Wang. A scholar is included among the top collaborators of Jian‐She Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian‐She Wang. Jian‐She Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 2
4 2
5 2
6 1
7 9
8 1
9 2
10 4
11 9
12 11
13 2
14 19
15 9
16 4
17 37
18 24
19
A new frame-shifting mutation of UGT1A1 gene causes type I Crigler-Najjar syndrome.
4
20 43

About Jian‐She Wang

Jian‐She Wang is a scholar working on Clinical Biochemistry, Hepatology and Surgery, having authored 104 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pediatric Hepatobiliary Diseases and Treatments (46 papers), Drug Transport and Resistance Mechanisms (27 papers) and Metabolism and Genetic Disorders (23 papers). The work is most often cited by research in Hepatology (360 citations), Clinical Biochemistry (173 citations) and Epidemiology (459 citations). Jian‐She Wang has collaborated with scholars based in China, United States and Austria. Frequent co-authors include Yi Lu, Jing‐Yu Gong, Meihong Zhang, Yi‐Ling Qiu, Xiuzhen Zhang, Kuerbanjiang Abuduxikuer, A. S. Knisely, Liting Li, Xin‐Bao Xie and Jiaqi Li. Their work appears in journals such as PLoS ONE, Hepatology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026